Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture. (2017)

First Author: Pollock J
Attributed to:  FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/btpr.2492

PubMed Identifier: 28480535

Publication URI: http://europepmc.org/abstract/MED/28480535

Type: Journal Article/Review

Volume: 33

Parent Publication: Biotechnology progress

Issue: 4

ISSN: 1520-6033